BETA-ENDORPHIN LEVELS DURING HEROIN, METHADONE, BUPRENORPHINE, AND NALOXONE CHALLENGES - PRELIMINARY FINDINGS

被引:27
作者
KOSTEN, TR [1 ]
MORGAN, C [1 ]
KREEK, MJ [1 ]
机构
[1] ROCKEFELLER UNIV,BIOL ADDICT DIS LAB,NEW YORK,NY 10021
关键词
D O I
10.1016/0006-3223(92)90220-T
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Beta endorphin (BE) is a polypeptide agonist for the brain's endogenous opioid system. Levels of BE are elevated by opioid antagonists such as naloxone and depressed by short-acting agonists such as heroin and morphine; they become normalized during steady-state methadone. Buprenorphine (BUP) is a partial opioid agonist whose effects on BE levels were examined in six former heroin addicts and 14 methadone-maintained patients before and after being switched to sublingual BUP 2 mg daily for 1 month. In six former methadone-treated subjects BE levels also were measured after stopping BUP and after naloxone challenge. Levels of BE were not significantly lower in subjects started on BUP after stopping heroin (n = 6) (8.0 versus 8.1 ng/ml) or in subjects started on BUP after stopping methadone (n = 14) (11.6 vs 15.6 ng/ml). However, BE levels were lower on BUP than after naloxone challenge (n = 6) (7.0 versus 34.9 ng/ml). Levels of BE did not significantly change between the first 2 weeks ("early") and "later," although BE levels on methadone significantly correlated with BE levels on BUP in the "early" but not the "later" phase. The BE levels on BUP also did not differ from BE levels of unmedicated normals.
引用
收藏
页码:523 / 528
页数:6
相关论文
共 21 条
[1]  
CLEMENTJONES V, 1979, LANCET, V2, P380
[2]   BUPRENORPHINE - DEMONSTRATION OF PHYSICAL-DEPENDENCE LIABILITY [J].
DUM, J ;
BLASIG, J ;
HERZ, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 70 (03) :293-300
[3]   HEROIN-ADDICTION - BETA-ENDORPHIN IMMUNOREACTIVITY IN PLASMA INCREASES DURING WITHDRAWAL [J].
EMRICH, HM ;
NUSSELT, L ;
GRAMSCH, C ;
JOHN, S .
PHARMACOPSYCHIATRIA, 1983, 16 (03) :93-96
[4]   IMPAIRED CIRCADIAN RHYTHMICITY OF BETA-LIPOTROPHIN, BETA-ENDORPHIN AND ACTH IN HEROIN-ADDICTS [J].
FACCHINETTI, F ;
GRASSO, A ;
PETRAGLIA, F ;
PARRINI, D ;
VOLPE, A ;
GENAZZANI, AR .
ACTA ENDOCRINOLOGICA, 1984, 105 (02) :149-155
[5]   BETA-ENDORPHIN-LIKE IMMUNOACTIVITY IN THE PLASMA OF HEROIN-ADDICTS AND NORMAL SUBJECTS [J].
HO, WKK ;
WEN, HL ;
LING, N .
NEUROPHARMACOLOGY, 1980, 19 (01) :117-120
[6]   CSF-ENDORPHINS IN HEROIN-ADDICTS DURING METHADONE-MAINTENANCE AND DURING WITHDRAWAL [J].
HOLMSTRAND, J ;
GUNNE, LM ;
WAHLSTROM, A ;
TERENIUS, L .
PHARMACOPSYCHIATRIA, 1981, 14 (04) :126-128
[7]  
JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P510
[8]  
KOSTEN TR, 1990, PSYCHOPHARMACOL BULL, V26, P69
[9]   A PRELIMINARY-STUDY OF BETA-ENDORPHIN DURING CHRONIC NALTREXONE MAINTENANCE TREATMENT IN EX-OPIATE ADDICTS [J].
KOSTEN, TR ;
KREEK, MJ ;
RAGUNATH, J ;
KLEBER, HD .
LIFE SCIENCES, 1986, 39 (01) :55-59
[10]   CIRCADIAN-RHYTHMS AND LEVELS OF BETA-ENDORPHIN, ACTH, AND CORTISOL DURING CHRONIC METHADONE-MAINTENANCE TREATMENT IN HUMANS [J].
KREEK, MJ ;
WARDLAW, SL ;
HARTMAN, N ;
RAGHUNATH, J ;
FRIEDMAN, J ;
SCHNEIDER, B ;
FRANTZ, AG .
LIFE SCIENCES, 1983, 33 :409-411